Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption

INTRODUCTION: Bile acid malabsorption (BAM) is a socially debilitating disease characterised by high stool frequency and urgency caused by a spillover of bile acids into the colon. Bile acid sequestrants (BASs) have limited therapeutic effect but represent the only available treatment option. Cases...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMJ Open
Päätekijät: Kårhus, Martin Lund, Brønden, Andreas, Lyng Forman, Julie, Haaber, Anne, Vilsbøll, Tina, Sonne, David Peick, Knop, Filip Krag
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2021
Aiheet:
Gastroenterology and Hepatology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7871677/
https://ncbi.nlm.nih.gov/pubmed/33558360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-044711
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia